COMMON STOCK PURCHASE WARRANT THERMOGENESIS HOLDINGS, INC.ThermoGenesis Holdings, Inc. • March 21st, 2023 • Laboratory apparatus & furniture
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on September 20, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from ThermoGenesis Holdings, Inc., a Delaware corporation (the “Company”), up to 1,071,429 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 30th, 2014 • Thermogenesis Corp • Laboratory apparatus & furniture • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 27, 2014, between ThermoGenesis Corp., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 21st, 2023 • ThermoGenesis Holdings, Inc. • Laboratory apparatus & furniture
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 15, 2023, between ThermoGenesis Holdings, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
Date of Grant: 12-13-01 THERMOGENESIS CORP. NONQUALIFIED STOCK OPTION AGREEMENT THIS OPTION AGREEMENT MAY BE EXERCISED ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS CONTAINED HEREIN. THE GRANT OF THIS OPTION SHALL NOT IMPOSE AN OBLIGATION UPON THE...Nonqualified Stock Option Agreement • February 15th, 2002 • Thermogenesis Corp • Laboratory apparatus & furniture • California
PRE-FUNDED COMMON STOCK PURCHASE WARRANT CESCA THERAPEUTICS INC.Cesca Therapeutics Inc. • April 25th, 2019 • Laboratory apparatus & furniture • New York
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, YUAN LAN FANG or her assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cesca Therapeutics Inc., a Delaware corporation (the “Company”), up to 4,444,444 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EMPLOYMENT AGREEMENT for Matthew T. PlavanEmployment Agreement • May 5th, 2005 • Thermogenesis Corp • Laboratory apparatus & furniture • California
SECURITIES PURCHASE AGREEMENT ThermoGenesis Corp. 2711 Citrus Road Rancho Cordova, CA 95742 Ladies & Gentlemen: The undersigned, _____________________________(the "Investor"), hereby confirms its agreement with you as follows: 1. This Securities...Securities Purchase Agreement • March 10th, 2004 • Thermogenesis Corp • Laboratory apparatus & furniture • New York
SERIES B COMMON STOCK PURCHASE WARRANT CESCA THERAPEUTICS, INC.Cesca Therapeutics Inc. • September 1st, 2015 • Laboratory apparatus & furniture
THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the earlier of (x) the date Shareholder Approval is received and effective or (y) February 29, 2016 (the “Initial Exercise Date”) and on or prior to the close of business on February 29, 2017 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cesca Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock; provided, however, as of the First Closing Date, only up to ______ Warrant Shares (as subject to adjustment hereunder) may be issued on exercise(s) of this Warrant, and the exercisability of the ______ additional Warrant Shares (as subject to adjustment hereunder) shall vest ratably from t
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 14th, 2018 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of [ ], 2018, between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
THERMOGENESIS CORP. and SERIES B CONVERTIBLE PREFERRED STOCK and COMMON STOCK PURCHASE WARRANTSSubscription Agreement • January 5th, 2000 • Thermogenesis Corp • Laboratory apparatus & furniture • California
LICENSE AGREEMENTLicense Agreement • April 14th, 1997 • Thermogenesis Corp • Laboratory apparatus & furniture • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 27th, 2020 • ThermoGenesis Holdings, Inc. • Laboratory apparatus & furniture • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 25, 2020, between ThermoGenesis Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 1st, 2015 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 31, 2015, between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
THERMOGENESIS CORP. EMPLOYMENT AGREEMENT FOR DAVID C. ADAMS THERMOGENESIS CORP. ("Employer"), and David C. Adams ("Employee"), agree as follows: 1. EMPLOYMENT. Employer employs Employee and Employee accepts employment with Employer on the terms and...Employment Agreement • September 29th, 1997 • Thermogenesis Corp • Laboratory apparatus & furniture • California
SECURITY AGREEMENTSecurity Agreement • September 1st, 2015 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This SECURITY AGREEMENT, dated as of August 31, 2015 (this “Agreement”), is among Cesca Therapeutics Inc., a Delaware corporation (the “Company” and, collectively with any Subsidiary of the Company that executes this Agreement including, including, without limitation, by delivery of an Additional Debtor Joinder in substantially the form of Annex A attached hereto, the “Debtors”) and the holders of the Company’s Senior Secured Convertible Debentures due thirty (30) years following their issuance, in the original aggregate principal amount of up to $15,000,000 (collectively, the “Debentures”) signatory hereto, their endorsees, transferees and assigns (collectively, the “Secured Parties”).
EMPLOYMENT AGREEMENT for Philip H. CoelhoEmployment Agreement • September 27th, 1999 • Thermogenesis Corp • Laboratory apparatus & furniture • California
W I T N E S S E T H:Registration Rights Agreement • January 5th, 2000 • Thermogenesis Corp • Laboratory apparatus & furniture • California
AT THE MARKET OFFERING AGREEMENTMarket Offering Agreement • December 13th, 2019 • ThermoGenesis Holdings, Inc. • Laboratory apparatus & furniture • New York
ThermoGenesis Holdings, Inc. f/k/a Cesca Therapeutics Inc., a corporation organized under the laws of Delaware (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:
STRICTLY CONFIDENTIAL ThermoGenesis Holdings, Inc.Letter Agreement • March 27th, 2020 • ThermoGenesis Holdings, Inc. • Laboratory apparatus & furniture • New York
STOCK PURCHASE AGREEMENT STOCK PURCHASE AGREEMENT made as of December ___, 1997 by and between THERMOGENESIS CORP., a Delaware corporation ("Seller") and the undersigned investor ("Buyer"). WHEREAS, Seller is offering (the "Offering") $3,250,000 of...Stock Purchase Agreement • January 9th, 1998 • Thermogenesis Corp • Laboratory apparatus & furniture • California
2,225,000 Units THERMOGENESIS CORP. PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • March 9th, 2011 • Thermogenesis Corp • Laboratory apparatus & furniture • New York
PRE-FUNDED COMMON STOCK PURCHASE WARRANT THERMOGENESIS HOLDINGS, INC.ThermoGenesis Holdings, Inc. • March 21st, 2023 • Laboratory apparatus & furniture
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from ThermoGenesis Holdings, Inc., a Delaware corporation (the “Company”), up to 946,429 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENTEquity Underwriting Agreement • January 31st, 2006 • Thermogenesis Corp • Laboratory apparatus & furniture • New York
ThermoGenesis Corp., a Delaware corporation (the “Company”) proposes to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representatives (the “Representatives”) an aggregate of 8,000,000 shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”) all of which will be sold by the Company. The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto. The Company also proposes to sell at the Underwriters’ option an aggregate of up to 800,000 additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below.
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • December 1st, 2017 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This letter (this “Agreement”) constitutes the agreement between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and Dawson James Securities, Inc. (“Dawson” or the “Placement Agent”) pursuant to which Dawson shall serve as the exclusive placement agent (the “Services”) for the Company, on a reasonable “best efforts” basis, in connection with the proposed offer and placement (the “Offering”) by the Company of its Securities (as defined Section 3 of this Agreement). The Company expressly acknowledges and agrees that Dawson’s obligations hereunder are on a reasonable “best efforts” basis only and that the execution of this Agreement does not constitute a commitment by Dawson to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of Dawson in placing the Securities.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 29th, 2018 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated of August 28, 2018 and is by and among Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and the purchaser(s) identified on the signature pages hereto (each a “Buyer” and collectively, the “Buyers”).
EXHIBIT 10 SUPPLY AGREEMENT ---------------- Clotalyst Thrombin Product THIS AGREEMENT, made and entered into this 29th day of March 2005 ("Effective Date"), by and between Cell Factors Technologies, Inc. ("CFT"), an Indiana corporation, and affiliate...Exhibit 10 • April 4th, 2005 • Thermogenesis Corp • Laboratory apparatus & furniture • Indiana
RECITALSInternational Distribution Agreement • October 18th, 2005 • Thermogenesis Corp • Laboratory apparatus & furniture
AT THE MARKET OFFERING AGREEMENT November 22, 2023Terms Agreement • November 22nd, 2023 • ThermoGenesis Holdings, Inc. • Laboratory apparatus & furniture • New York
ThermoGenesis Holdings, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:
EXHIBIT 10 DISTRIBUTION AND LICENSE AGREEMENT This Distribution and Manufacturing License Agreement ("Agreement") is entered into as of the 28th day of March, 2005 by and between Asahi Kasei Medical Co., Ltd., a Japanese corporation ("ASAHI") with an...Distribution and License Agreement • March 31st, 2005 • Thermogenesis Corp • Laboratory apparatus & furniture • California
Robin C. StraceyCesca Therapeutics Inc. • August 4th, 2016 • Laboratory apparatus & furniture • New York
This letter (the “Agreement”) constitutes the agreement between Maxim Group LLC (“Maxim” or the “Placement Agent”) and Cesca Therapeutics Inc., a Delaware corporation (the “Company”), that Maxim shall serve as the placement agent for the Company, on a best efforts basis, in connection with the proposed placement (the “Placement”) of an aggregate of 600,000 shares of (the “Securities”) of the Company’s common stock, par value $0.001 per share (“Common Stock”). The terms of the Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that Maxim would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the Placement, including but not limited to the Purchase Agreem
STRICTLY CONFIDENTIAL Cesca Therapeutics Inc.Letter Agreement • March 28th, 2018 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
RECITALSOem Supply Agreement • November 10th, 2005 • Thermogenesis Corp • Laboratory apparatus & furniture • California
CESCA THERAPEUTICS INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 15th, 2017 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • California
This Executive Employment Agreement (“Agreement”) is made and entered into as of November 13, 2017, by and between CESCA THERAPEUTICS INC., a Delaware corporation (“Employer”), and XIAOCHUN (CHRIS) XU (“Executive”).
UNIT PURCHASE AGREEMENT UNIT PURCHASE AGREEMENT made as of April 27, 2001 by and between THERMOGENESIS CORP., a Delaware corporation ("Seller") and the undersigned investor ("Buyer"). WHEREAS, Seller is offering (the "Offering") up to 78 units, each...Unit Purchase Agreement • May 11th, 2001 • Thermogenesis Corp • Laboratory apparatus & furniture • California
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 28th, 2018 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 26, 2018, between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
